The many faces of tau.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuron

• Publication date

  2011-05-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2011.04.009PMID 21555069PMCID PMC3319390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

  2014cited by this paper
• Feed‐forward hierarchical model of the ventral visual stream applied to functional brain image classification

  2014cited by this paper
• "Lest we forget you--methylene blue...".

  2011cited by this paper
• Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.

  2011cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011influential reference
• Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant

  2011cited by this paper
• Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation

  2011cited by this paper
• Alzheimer's disease.

  2011influential reference
• The acetylation of tau inhibits its function and promotes pathological tau aggregation.

  2011influential reference
• Emerging Histomorphologic Phenotypes of Chronic Traumatic Encephalopathy in American Athletes

  2011cited by this paper
• Caspase activation precedes and leads to tangles

  2010cited by this paper
• Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

  2010influential reference
• Nuclear Tau, a Key Player in Neuronal DNA Protection*

  2010cited by this paper
• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  2010influential reference
• Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy

  2010cited by this paper
• Monte carlo simulations of tau proteins: effect of phosphorylation.

  2010cited by this paper
• Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein

  2010cited by this paper
• Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice.

  2010cited by this paper
• Probing the biology of Alzheimer's disease in mice.

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010influential reference
• Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss*

  2010cited by this paper
• Role of tau protein on neocortical and hippocampal oscillatory patterns

  2010cited by this paper
• Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.

  2010cited by this paper
• Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.

  2010cited by this paper
• A role for FKBP52 in Tau protein function

  2010cited by this paper
• Essential role of tau phosphorylation in adult hippocampal neurogenesis

  2010cited by this paper
• Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

  2010cited by this paper
• Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

  2010influential reference
• Deletion of tau attenuates heat shock‐induced injury in cultured cortical neurons

  2010cited by this paper
• Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding*

  2010cited by this paper
• CSF biomarkers predict a more malignant outcome in Alzheimer disease

  2010cited by this paper
• Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice.

  2010cited by this paper
• Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice

  2010influential reference
• Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

  2010cited by this paper
• Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

  2010cited by this paper
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• Secretion of human tau fragments resembling CSF‐tau in Alzheimer's disease is modulated by the presence of the exon 2 insert

  2010cited by this paper
• Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

  2010cited by this paper
• Amyloid oligomers: formation and toxicity of Aβ oligomers

  2010cited by this paper
• Lithium: Updated Human Knowledge Using an Evidence-Based Approach

  2009cited by this paper
• Faculty Opinions recommendation of Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.

  2009cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• LRRK2 and neurodegeneration

  2009cited by this paper
• Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.

  2009cited by this paper
• Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

  2009cited by this paper
• Tau – an inhibitor of deacetylase HDAC6 function

  2009cited by this paper
• Microtubule‐associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions

  2009cited by this paper
• Tau-focused immunotherapy for Alzheimer's disease and related tauopathies.

  2009cited by this paper
• Lithium: Updated Human Knowledge Using an Evidence-Based Approach

  2009cited by this paper
• Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.

  2009cited by this paper
• The proline-rich domain of tau plays a role in interactions with actin

  2009cited by this paper
• Addressing Alzheimer's disease tangles: from NAP to AL-108.

  2009cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• Transglutaminases and Transglutaminase‐Catalyzed Cross‐Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

  2009cited by this paper
• Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy

  2009cited by this paper
• Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

  2009influential reference
• Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

  2009cited by this paper
• Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau

  2009cited by this paper
• Lithium: Updated Human Knowledge Using an Evidence-Based Approach

  2009cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

  2008cited by this paper
• The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

  2008influential reference
• A possible link between astrocyte activation and tau nitration in Alzheimer's disease.

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

  2008cited by this paper
• Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases*

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• GSK-3β Is Required for Memory Reconsolidation in Adult Brain

  2008cited by this paper
• The pathogenesis of Niemann–Pick type C disease: a role for autophagy?

  2008cited by this paper
• Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies

  2008cited by this paper
• Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration.

  2008cited by this paper
• Mechanisms and functional implications of adult neurogenesis.

  2008cited by this paper
• Hope in Alzheimer's fight emerges from unexpected places

  2008cited by this paper
• Neuron-specific recombination by Cre recombinase inserted into the murine tau locus.

  2008influential reference
• Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

  2008cited by this paper
• Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

  2008cited by this paper
• Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells.

  2008cited by this paper
• Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation*

  2008cited by this paper
• Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.

  2008cited by this paper
• Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements

  2007cited by this paper
• High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation.

  2007cited by this paper
• LTP inhibits LTD in the hippocampus via regulation of GSK3beta.

  2007cited by this paper
• Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus

  2007cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007influential reference
• Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms

  2007cited by this paper
• Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo

  2007influential reference
• Granular tau oligomers as intermediates of tau filaments.

  2007cited by this paper
• Assembly of two distinct dimers and higher‐order oligomers from full‐length tau

  2007cited by this paper
• Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain

  2007cited by this paper
• Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

  2007cited by this paper
• The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

  2007cited by this paper
• Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models*

  2007cited by this paper
• Tau impacts on growth-factor-stimulated actin remodeling

  2007cited by this paper
• Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model

  2007cited by this paper
• Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

  2007cited by this paper
• Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation*

  2006cited by this paper

• Salivary total tau: a clinically practical measure of tau neuropathology in Alzheimer’s disease

  2026cites this paper
• Revealing the conformational landscape of tau P → L mutants in R23 tau macromolecule: A pathway to targeted therapeutic design.

  2026cites this paper
• Big Tau: Structure, Evolutionary Divergence, and Emerging Roles in Cytoskeletal Dynamics and Tauopathies

  2026cites this paper
• Updates on tau-related drug targets and potential disease-modifying therapies for Alzheimer's disease.

  2025cites this paper
• Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration

  2025cites this paper
• Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease.

  2025cites this paper
• Advancements in diagnosing Post-concussion Syndrome: insights into epidemiology, pathophysiology, neuropathology, neuroimaging, and salivary biomarkers

  2025cites this paper
• Effect of stress on neuronal cell: Morphological to molecular approach.

  2025cites this paper
• The Direction and Future of Alzheimer’s Treatment

  2025influential citation
• Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy

  2025cites this paper
• The Application of Directly Induced Neurons into Neurodegenerative Disease Modeling.

  2025cites this paper
• Tau post-translational modifications in Alzheimer's disease: insights into pathogenesis, therapeutic strategies, and diagnostic advances

  2025cites this paper
• A review of mitochondrial dysfunction, pathophysiology and therapeutic prospects in neurodegenerative diseases

  2025cites this paper
• Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss

  2025cites this paper
• Rational Modulation of Liquid–Liquid Phase Separation Offers Novel Ways to Combat Tauopathies

  2025cites this paper
• Early disruption of neurogenesis and neural architecture by Amyloid-β and Tau during Drosophila development

  2025cites this paper
• Tau-seed interactome analysis reveals distinct functional signatures in Alzheimer’s disease across model systems

  2025cites this paper
• Brain Networks Route Neurodegeneration Patterns in Patients with Progressive Supranuclear Palsy

  2025cites this paper
• The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

  2025cites this paper
• Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

  2025cites this paper
• The many roads to dementia: a systems view of Alzheimer's disease

  2025cites this paper
• Artificial microRNAs targeting Tau enable post-symptomatic functional recovery in aged tauopathy mice

  2025cites this paper
• Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics

  2025cites this paper
• The N-terminal domain of COMPANION OF CELLULOSE SYNTHASE1 promotes microtubule array formation in Arabidopsis.

  2025cites this paper
• Tau aggregation induces cell death in iPSC-derived neurons

  2025cites this paper
• The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer's disease.

  2025cites this paper
• Brain Injury Biomarkers in Humans Undergoing General Anaesthesia and Noncerebral Surgery

  2025cites this paper
• Effects of interval exercise and diurnal variation on blood biomarkers for sport-related concussion: A crossover cohort study.

  2025cites this paper
• Tau protein aggregation: A therapeutic target for neurodegenerative diseases.

  2025cites this paper
• Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component

  2025cites this paper
• Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments

  2025cites this paper
• Tau protein structure and dynamics.

  2025cites this paper
• Albumin antagonizes Alzheimer's disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation.

  2025cites this paper
• The aggregation propensity of Tau and amyloid-β in Alzheimer's disease.

  2025cites this paper
• Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model

  2025cites this paper
• Surface-enhanced Raman scattering for the detection of biomarkers of neurodegenerative diseases: A review

  2025cites this paper
• Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice

  2024cites this paper
• Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction

  2024cites this paper
• Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?

  2024cites this paper
• Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease

  2024cites this paper
• Pathological Impact of Redox Post-Translational Modifications

  2024cites this paper
• Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease

  2024cites this paper
• Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review

  2024cites this paper
• Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease

  2024cites this paper
• Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase-Separated Coacervates.

  2024cites this paper
• Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.

  2024cites this paper
• Molecular Interactions between Tau Protein and TIA1: Distinguishing Physiological Condensates from Pathological Fibrils.

  2024cites this paper
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

  2024cites this paper
• Prion protein prevents the inhibition of large-conductance calcium-activated potassium channel by Tau peptide K18 oligomers.

  2024cites this paper
• Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target.

  2024cites this paper
• Development of a sensor to detect methylmercury toxicity

  2024cites this paper
• Nanotechnology for tau pathology in Alzheimer's disease

  2024cites this paper
• Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase Separated Coacervates

  2024cites this paper
• Influence of Tau on neurotoxicity and cerebral vasculature impairment associated with Alzheimer's disease.

  2024cites this paper
• Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity.

  2024cites this paper
• MAPT-A152T mutation drives neuronal hyperactivity through Fyn-NMDAR signaling in human iPSC-Derived neurons: Insights into Alzheimer's pathogenesis

  2024cites this paper
• Genomic stress and impaired DNA repair in Alzheimer disease.

  2024cites this paper
• Recent Advances in Mapping Protein Self-Assembly and Aggregation for Common Proteinopathies

  2024cites this paper
• Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia

  2024cites this paper
• Quantification of Methylation and Phosphorylation Stoichiometry.

  2024cites this paper
• Nutrient Sensing Receptor GPRC6A Regulates mTORC1 Signaling and Tau Biology

  2024cites this paper
• Tau-S214 phosphorylation inhibits Fyn kinase interaction and increases the decay time of NMDAR-mediated current.

  2024cites this paper
• Updates in Alzheimer's disease: from basic research to diagnosis and therapies

  2024cites this paper
• Mapping the Multiscale Proteomic Organization of Cellular and Disease Phenotypes.

  2024cites this paper
• Tau Protein and β-Amyloid Associated with Neurodegeneration in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis (EAE), a Mouse Model of Multiple Sclerosis

  2024cites this paper
• Interactions of Polyphenolic Gallotannins with Amyloidogenic Polypeptides Associated with Alzheimer's Disease: From Molecular Insights to Physiological Significance.

  2023cites this paper
• Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort

  2023cites this paper
• Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs

  2023cites this paper
• Tridimensional Structural Analysis of Tau Isoforms Generated by Intronic Retention

  2023cites this paper
• Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy

  2023cites this paper
• Imaging glymphatic response to glioblastoma

  2023cites this paper
• Blood biomarkers for traumatic brain injury: A narrative review of current evidence

  2023cites this paper
• Tau forms synaptic nano-biomolecular condensates controlling the dynamic clustering of recycling synaptic vesicles

  2023cites this paper
• Breast‐to‐brain metastasis is exacerbated with chemotherapy through blood–cerebrospinal fluid barrier and induces Alzheimer's‐like pathology

  2023cites this paper
• Autophagy in Disease Onset and Progression

  2023cites this paper
• Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases

  2023cites this paper
• Tau suppresses microtubule-regulated pancreatic insulin secretion

  2023cites this paper
• Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer’s Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion

  2023cites this paper
• Liquid - liquid phase separation of tau: Driving forces, regulation, and biological implications.

  2023cites this paper
• Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases

  2023cites this paper
• Advances in biomarkers and diagnostic significance of organ aging

  2023cites this paper
• Rhythms in barriers and fluids: Circadian clock regulation in the aging neurovascular unit.

  2023cites this paper
• The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

  2023cites this paper
• Biomedical research brings mTBI biomarkers a step closer to the bedside - implementation in clinical practice.

  2023cites this paper
• Targeting a vulnerable septum-hippocampus cholinergic circuit in a critical time window ameliorates tau-impaired memory consolidation

  2023cites this paper
• Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

  2023cites this paper
• A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy

  2023cites this paper
• Association of tau protein and Alzheimers disease

  2023cites this paper
• Clinical efficacy and controversies of aducanumab

  2023cites this paper
• Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system

  2023cites this paper
• Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease

  2023cites this paper
• Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study

  2023cites this paper
• Magnetic resonance imaging-based progress in human glymphatic system research

  2023cites this paper
• Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies

  2023cites this paper
• Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency.

  2023cites this paper
• The past and present of therapeutic strategy for Alzheimer’s diseases: potential for stem cell therapy

  2023cites this paper
• Diagnosis of cerebral malaria: Tools to reduce Plasmodium falciparum associated mortality

  2023cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• Friend or foe: role of pathological tau in neuronal death.

  2023cites this paper
• Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?

  2023cites this paper